title: Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
abstract: HSV-1 infection of the cornea leads to a potentially blinding immunoinflammatory lesion of the cornea, termed herpetic stromal keratitis. It has also been shown that one of the factors limiting inflammation of the cornea is the presence of Fas ligand (FasL) on corneal epithelium and endothelium. In this study, the role played by FasL expression in the cornea following acute infection with HSV-1 was determined. Both BALB/c and C57BL/6 (B6) mice with HSV-1 infection were compared with their lpr and gld counterparts. Results indicated that mice bearing mutations in the Fas Ag (lpr) displayed the most severe disease, whereas the FasL-defective gld mouse displayed an intermediate phenotype. It was further demonstrated that increased disease was due to lack of Fas expression on bone marrow-derived cells. Of interest, although virus persisted slightly longer in the corneas of mice bearing lpr and gld mutations, the persistence of infectious virus in the trigeminal ganglia was the same for all strains infected. Further, B6 mice bearing lpr and gld mutations were also more resistant to virus-induced mortality than were wild-type B6 mice. Thus, neither disease nor mortality correlated with viral replication in these mice. Collectively, the findings indicate that the presence of FasL on the cornea restricts the entry of Fas(+) bone marrow-derived inflammatory cells and thus reduces the severity of HSK.
authors.affiliation: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Jessica E
authors.initials: JE
authors.lastname: Morris
authors.forename: Stephanie
authors.initials: S
authors.lastname: Zobell
authors.forename: Xiao-Tang
authors.initials: XT
authors.lastname: Yin
authors.forename: Hamideh
authors.initials: H
authors.lastname: Zakeri
authors.forename: Bretton C
authors.initials: BC
authors.lastname: Summers
authors.forename: David A
authors.initials: DA
authors.lastname: Leib
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Stuart
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000473:pathology; D060467:Disease Resistance / Q000235:genetics / Q000276:immunology; D053222:Fas Ligand Protein / Q000172:deficiency / Q000235:genetics*; D015967:Gene Expression Regulation, Viral / Q000276:immunology*; D020022:Genetic Predisposition to Disease; D018259:Herpesvirus 1, Human / Q000276:immunology*; D007249:Inflammation / Q000235:genetics / Q000276:immunology / Q000473:pathology; D016849:Keratitis, Herpetic / Q000235:genetics / Q000276:immunology* / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D011828:Radiation Chimera / Q000276:immunology; D012720:Severity of Illness Index; D017154:Stromal Cells / Q000276:immunology / Q000473:pathology / Q000821:virology; D015854:Up-Regulation / Q000235:genetics / Q000276:immunology*; D019562:Viral Load / Q000235:genetics / Q000276:immunology; D019014:fas Receptor / Q000172:deficiency / Q000235:genetics*
chemical_list: D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D019014:fas Receptor